Is Bullous Pemphigoid Fatal? Risks, Treatment, and Survival
At a Glance
Bullous pemphigoid can be life-threatening, but it is not inevitably fatal. Serious outcomes are more often linked to widespread skin damage, infections, treatment side effects, older age, and other health conditions, so careful treatment and monitoring are important.
In this answer
3 sections
If you are researching bullous pemphigoid (BP) online, you may have come across alarming statistics about survival rates. It is completely normal to feel terrified when seeing these numbers, but it is essential to understand the context behind them.
Yes, bullous pemphigoid can be a serious and sometimes life-threatening condition, but many people achieve excellent control with treatment. The skin blisters themselves are rarely the direct cause of death. Instead, severe outcomes in BP are usually multifactorial—meaning they result from a combination of the disease itself, the side effects of treatments, and the person’s overall age and pre-existing health.
By understanding where the risks actually come from, you and your medical team can take active steps to manage your care safely and protect your overall health.
What Drives the Risks?
The risks associated with BP generally fall into three main categories:
1. The Disease Itself
BP is an autoimmune condition, but it is not contagious. However, extensive blistering breaks down the skin’s natural protective barrier. Widespread open sores can lead to significant fluid loss, poor nutrition, and severe bacterial skin infections [1][2]. Because uncontrolled BP poses these serious risks, effectively calming the disease is a critical first step in protecting your health.
2. Treatment Side Effects
To stop the blistering, doctors often prescribe systemic (whole-body, usually oral) corticosteroids, such as prednisone. While these medications can be lifesaving and act quickly to control the disease, long-term or high-dose use comes with serious risks [3]. High doses suppress your immune system, making you more vulnerable to severe infections like pneumonia [3][2]. Studies consistently show that infections are one of the leading drivers of severe complications in BP patients [2].
Steroids can also elevate blood pressure, cause fluid retention, and worsen or trigger diabetes, which further increases the risk of infection [2][3]. Because of this, the goal is always a carefully balanced plan: using enough medication to control the blisters, while slowly lowering the dose to reduce toxicity. Never stop or taper oral steroids abruptly on your own, as this can be extremely dangerous.
3. Pre-Existing Health Conditions (Comorbidities)
Because BP most commonly develops in older adults, many patients already have other health challenges when they are diagnosed. Research shows that a patient’s underlying health plays a massive role in their prognosis. Conditions such as heart disease, previous strokes, dementia, and kidney disease can make it much harder for the body to recover from the physical stress of BP and its treatments [4][5][6].
Making Sense of Online Statistics
You might read online that the one-year mortality rate for bullous pemphigoid is around 23% to 25% [7][8]. While these numbers sound frightening, they are not a universal prediction for your personal outcome.
These statistics often come from older studies (such as groups of patients treated between 2001 and 2012) and represent all-cause mortality—meaning they count deaths from any cause, including old age and pre-existing heart disease, not just the skin condition [7]. Because BP mostly affects people in their late 70s, 80s, and 90s, these population statistics strongly reflect the overall frailty of older adults [9]. If you are relatively healthy, or if your medical team carefully individualizes your treatment to avoid severe side effects, your personal risk profile will be different.
Protecting Your Health Today
Careful medical management and monitoring can help reduce preventable complications.
- Finding the Right Treatment Balance: Depending on the severity of your BP, your doctor might discuss alternatives to high-dose oral steroids. Using potent full-body topical steroid creams or oral antibiotics like doxycycline may reduce the risk of severe medication side effects, though they may take longer to completely clear the blisters [10][11]. Keep in mind that full-body creams can be physically exhausting to apply and usually require daily help from a dedicated caregiver.
- Monitor Closely for Infection: Because infection is a major risk, keeping your skin clean and following your clinical team’s wound-care instructions is critical [2]. Call your doctor the same day if you notice spreading redness, warmth, increased pain, or pus around a blister.
- Know When to Seek Emergency Help: Go to the emergency room or seek urgent help for difficulty breathing, fainting, severe weakness, or sudden confusion. Note that in older adults—or those taking steroids—a serious infection may not always cause a high fever.
- Manage Other Conditions: Work closely with your primary care doctor to keep your blood sugar, blood pressure, and bone health heavily monitored while you are undergoing BP treatment.
Common questions in this guide
Can bullous pemphigoid be fatal?
What causes serious complications in bullous pemphigoid?
Does the reported one-year death rate predict my outcome?
Can treatment reduce the risk of serious outcomes from bullous pemphigoid?
What signs of infection should I report?
When should I seek emergency care with bullous pemphigoid?
What health checks are important during bullous pemphigoid treatment?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How extensive is my blistering, and what is our plan to safely control it while minimizing side effects?
- 2.What is the plan for safely tapering my oral steroids over time?
- 3.Am I a candidate for alternative treatments like doxycycline or whole-body topical creams, and what are the pros and cons of these options for me?
- 4.What specific signs of infection should I watch for, and who do I contact after hours or on weekends?
- 5.Given my current health, what extra monitoring do I need for my blood sugar, blood pressure, and bone health while on these medications?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Successful Treatment of Bullous Pemphigoid Lesions by Berberine Stamp Therapy: A Case Report and Literature Review.
Cheng L, Wang Y, Lu H, et al.
Frontiers in medicine 2022; (9()):938761 doi:10.3389/fmed.2022.938761.
PMID: 35847802 - 2
Assessment of the Characteristics and Associated Factors of Infectious Complications in Bullous Pemphigoid.
Chen J, Mao X, Zhao W, et al.
Frontiers in immunology 2020; (11()):1607 doi:10.3389/fimmu.2020.01607.
PMID: 32793235 - 3
Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroids.
Kridin K, Bieber K, Vorobyev A, et al.
The British journal of dermatology 2024; (191(4)):539-547 doi:10.1093/bjd/ljae219.
PMID: 38798074 - 4
Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.
Chen X, Zhang Y, Luo Z, et al.
PloS one 2022; (17(4)):e0264705 doi:10.1371/journal.pone.0264705.
PMID: 35427358 - 5
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study.
Bardazzi F, Filippi F, Chessa MA, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2022; (36(12)):2473-2481 doi:10.1111/jdv.18441.
PMID: 35857348 - 6
Chronic disease associated with bullous pemphigoid risk: A systematic review and meta-analysis.
Siranart N, Chumpangern Y, Phutinart S, et al.
JAAD international 2024; (17()):141-152 doi:10.1016/j.jdin.2024.08.010.
PMID: 39444540 - 7
Anti-BP180 autoantibody levels at diagnosis correlate with 1-year mortality rates in patients with bullous pemphigoid.
Monshi B, Gulz L, Piringer B, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(7)):1583-1589 doi:10.1111/jdv.16363.
PMID: 32170780 - 8
Bullous pemphigoid.
Miyamoto D, Santi CG, Aoki V, Maruta CW
Anais brasileiros de dermatologia 2019; (94(2)):133-146 doi:10.1590/abd1806-4841.20199007.
PMID: 31090818 - 9
Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis.
Liu YD, Wang YH, Ye YC, et al.
Archives of dermatological research 2017; (309(5)):335-347 doi:10.1007/s00403-017-1736-1.
PMID: 28317060 - 10
Interventions for bullous pemphigoid.
Singh S, Kirtschig G, Anchan VN, et al.
The Cochrane database of systematic reviews 2023; (8()):CD002292 doi:10.1002/14651858.CD002292.pub4.
PMID: 37572360 - 11
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.
Williams HC, Wojnarowska F, Kirtschig G, et al.
Lancet (London, England) 2017; (389(10079)):1630-1638 doi:10.1016/S0140-6736(17)30560-3.
PMID: 28279484
This page is for informational purposes only and does not constitute medical advice. Do not change or stop bullous pemphigoid treatment without speaking with your clinician, and seek urgent care for emergency symptoms.
Get notified when new evidence is published on Bullous pemphigoid.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.